1. Introduction to the history of Flavoprotein discovery {#s0010}
========================================================

The yeast *Saccharomyces cerevisiae* played a central role in the discovery of flavoproteins as Otto Warburg and his collaborators were the first to isolate a "yellow ferment" from yeast cells [@bb0005]. Further studies by Theorell led to the concept of reversible association of co-enzyme and apo-enzyme to form the active holo-enzyme [@bb0010]. The isolation of other (new) yellow ferments from yeast prompted the renaming of the original ferment in to "old yellow ferment" (old yellow enzyme = OYE) [@bb0015]. Although it was demonstrated that OYE is reduced by NADPH [@bb0005; @bb0020] the physiological electron accepting substrate(s) remains uncertain despite its reported role in the maintenance of the cytoskeleton [@bb0025]. This may have contributed to the persistent use of OYE instead of the official classification as NAD(P)H dehydrogenase (EC 1.6.99.1).

Despite the elusive nature of the physiological substrate(s), OYE rapidly developed in to an important model flavoenzyme culminating in the determination of the nucleotide sequence of *oye2* and *oye3* as well as the elucidation of its three-dimensional structure by X-ray crystallography [@bb0030; @bb0035; @bb0040]. The detailed biochemical characterisation of OYE also led to the identification of a number of artificial substrates, such as *N*-ethylmaleimide, cyclohex-2-enone and nitroolefins [@bb0040; @bb0045; @bb0050]. All of these substrates share a common structural motif consisting of an electron-withdrawing group (e.g. a carbonyl or nitro group) in α-position of a carbon--carbon double bond. The remarkably broad range of accepted substrates rendered OYE an ideal tool for biocatalytic applications exploited in numerous studies [@bb0055; @bb0060; @bb0065; @bb0070; @bb0075]. These efforts were further stimulated by the discovery of OYE homologs in many eubacteria as well as plant species in the 1990s [@bb0080; @bb0085; @bb0090; @bb0095; @bb0100; @bb0105; @bb0110; @bb0115]. Plant OYE homologs were of particular interest because of their well-defined role in the biosynthesis of the plant hormone jasmonate, which plays a crucial role in the plant\'s defense response to pathogens [@bb0120; @bb0125]. In all reported cases, the natural substrates exhibited the structural motif discovered in previous studies with yeast OYE. Hence, the yeast enzyme also became the paradigm for the class of "ene-reductases" now widely used for the synthesis of a variety of useful chemicals. Curiously, the broad range of activated "enes" accepted by OYEs as substrates is in stark contrast to its invoked physiological role as a reductase of disulphide bonds in oxidatively damaged proteins of the cytoskeleton, such as actin [@bb0025].

2. General aspects of the yeast flavoproteome {#s0015}
=============================================

The yeast genome contains 68 genes encoding for a flavin-dependent protein and thus 1.1% of all yeast proteins (5885 protein-encoding genes [@bb0130]) have a requirement for either FMN or FAD. Owing to the presence of several flavoprotein families, which will be discussed further below, these 68 genes give rise to 47 defined biochemical roles. Thirty-five flavoproteins require FAD (74%) and fifteen require FMN (26%). Yeast also possesses three diflavin enzymes, which harbor both FMN and FAD ([Table 1](#t0005){ref-type="table"}). The utilization of FMN and FAD in yeast flavoproteins is very similar to the distribution found in a global analysis across all kingdoms of life [@bb0135] and does not have the bias towards FAD as found for the human flavoproteome [@bb0140]. Covalent flavinylation, which is statistically found in ca. 10% of flavoproteins, is underrepresented in the yeast flavoproteome with only two enzymes, succinate dehydrogenase (Sdh1p) and [l]{.smallcaps}-arabinono-1,4-lactone oxidase (Alo1p) featuring a covalent bond between the *N*(3)-nitrogen of a histidine residue and the 8-methyl group of the isoalloxazine ring system ([Table 1](#t0005){ref-type="table"}). Both of these enzymes operate in yeast mitochondria and are located in the inner (Sdh1p) and outer (Alo1p) membrane. The scarcity of covalent flavoproteins is linked to the relative absence of the structural clan FAD_PCMH (with the exception of Alo1p), which features many examples of mono- and even bi-covalent flavinylation [@bb0135; @bb0140].

Structural information through X-ray crystallographic analysis is available for about one third of yeast flavoproteins listed in [Table 1](#t0005){ref-type="table"} (plain font in column "Structure clan/family"). In addition, the three-dimensional structure can be inferred from the known structure of homologs from other species (italics in column "Structure clan/family"). In some cases the structure of yeast flavoproteins served as paradigms for a family of enzymes, for example yeast OYEs [@bb0030; @bb0145] and more recently kynurenine monooxygenase [@bb0150]. The general difficulties to elucidate the structure of integral or membrane associated proteins is also seen for flavoproteins (see [Table 1](#t0005){ref-type="table"}).

[Table 1](#t0005){ref-type="table"} also provides information on the localisation of flavoproteins in the yeast cell. More than half of yeast flavoproteins (36 entries in [Table 1](#t0005){ref-type="table"}) operate in the mitochondrion. Many of these are directly participating in redox reactions connected to the electron transport chain (ETC) (see also next section). Seventeen flavoproteins are located in the cytoplasm and only a few in the nucleus (Dus1-4p, Phr1p, Aif1p), endoplasmic reticulum (Aim14p, Cbr1p, Erg1p, Ero1p, Erv2p, Fmo1p, Ncp1p, Pga3p, Tyw1p) or the peroxisome (Pox1p). Requirement for the same flavoenzyme activity in different cellular compartments is either satisfied by expression of isozymes (e.g. Dld1-3p are found in either the cytoplasm, the inner mitochondrial membrane or the matrix) or the same flavoenzyme is present in multiple compartments (e.g. Cbr1p, Pga3p, Ncp1p, Trr1/2p, Yhb1p, Fas1p, Phr1p, Aif1p).

3. Flavoproteins, the stewards of iron {#s0020}
======================================

A remarkable result of our analysis concerns the multi-layered relationship between flavins and iron. As discussed in more detail in the next section, flavin-dependent ferric reductases (Fre1p-8p) are essential for reduction of ferric iron (and copper), which is prerequisite for iron (and copper) uptake by yeast transporters (permeases). Moreover, in several flavoproteins the flavin is responsible for the reduction of either heme iron or an iron--sulfur cluster ([Table 1](#t0005){ref-type="table"} and [Scheme 1](#sch0005){ref-type="fig"}). Prominent examples include succinate dehydrogenase (Sdh1p), (Aim1p), nitric oxide oxidoreductase and [l]{.smallcaps}-lactate:cytochrome c oxido reductase (flavocytochrome b~2~). In addition to this intramolecular electron transfer, two yeast flavoproteins, Cyc2p and Tah18p, are involved in intermolecular electron transfer. In the case of Cyc2p, which is located in the inner mitochondrial membrane with its FAD-containing active site exposed to the intermembrane space, the enzyme reduces Fe(III) and participates in the incorporation of the heme prosthetic group into apocytochrome c and c1 [@bb0155; @bb0160]. Similarly, the diflavin reductase Tah18p forms a complex with Dre2p and provides electrons derived from NADPH to support the biosynthesis of two iron--sulfur clusters [@bb0165]. Recently, Tah18p was reported to be involved in NO generation in yeast and hence it is conceivable that it has more clients than Dre2p [@bb0170]. Thus flavoproteins fulfill various crucial tasks ranging from iron uptake, delivery of electrons to the mitochondrial electron transport chain, reduction of cytochrome-dependent reductases, biogenesis of iron--sulfur clusters and insertion of the heme cofactor into apocytochromes.

4. Flavoprotein families in yeast {#s0025}
=================================

As mentioned above, the yeast flavoproteome contains several families of flavoproteins, which catalyze identical or similar reactions. The largest group are the ferric/cupric reductases encoded by *fre*1-8 (see [Table 1](#t0005){ref-type="table"}, entry 38). *Fre*1 and *fre*2 are metalloregulated by either iron or copper availability and the encoded metalloreductases reduce Fe(III) and Cu(II) at the expense of NADPH [@bb0175]. In addition to *fre*1 and *fre*2, the yeast genome contains six homologous genes, termed *fre*3-8. *Fre*3-6 are regulated by iron whereas *fre*7 is copper-regulated [@bb0180; @bb0185]. *Fre*8 and the homologous *aim*14 are not regulated by iron or copper suggesting a different role for these proteins [@bb0180]. Recently, it was demonstrated that *aim*14 encodes an NADPH-oxidase, which produces superoxide in the endoplasmatic reticulum [@bb0190] and it is thus conceivable that *fre*8 also encodes an enzyme with similar properties. This notion is also supported by pair-wise sequence alignments showing the highest identity (30.6%) and similarity (56.5%) on the amino acid level between *fre*8 and *aim*14 within this family of flavoproteins [@bb0180]. Again, these functions highlight the importance of flavoenzymes for iron uptake and reduction as introduced in the previous section.

The second largest family comprise four tRNA-dihydrouridine synthases encoded by *dus1-4* ([Table 1](#t0005){ref-type="table"}, entry 5). The reduction of uracils to dihydrouridines in tRNA is one of the most common modifications of nucleosides in tRNA in all kingdoms of life [@bb0195]. A recent mechanistic study employing Dus2p revealed that reduction of uracil to dihydrouracil (see [Scheme 2](#sch0010){ref-type="fig"}, top) is promoted by other tRNA modifications suggesting that tRNA maturation may occur in an ordered fashion [@bb0200]. Cytoplasmic tRNA in *S. cerevisiae* contains dihydrouridine in the D loop at positions 16, 17, 20, 20A, 20B and at the base of the variable arm at position 47. The four yeast enzymes exclusively reduce uracils in specific positions in tRNA: Dus1p reduces uracils in positions 16 and 17, Dus2p in position 20, Dus3p in position 47 and Dus4p in positions 20a and 20b. Thus these four enzymes are sufficient to generate all dihydrouridine modifications known in yeast [@bb0205]. In humans, only one dihydrouridine synthase homologous to yeast Dus2p (42% identity) was identified so far, which reduces uracil in tRNA for phenylalanine [@bb0140; @bb0210]. The human enzyme appears to be upregulated in malignant tissues resulting in higher levels of dihydrouridine [@bb0210]. Despite its putative role in malignancy the specificity and exact role of the human enzyme remains unclear.

In addition to reduction of uracil, the flavoenzyme Mto1p (also termed GidA) is involved in the biosynthesis of modifications at the C5-position of the uracil base in tRNAs [@bb0215; @bb0220]. Depending on the nitrogen source, ammonia or glycine, this reaction leads to the formation of either 5-aminomethyl- or 5-carboxymethylaminomethyluridine ([Scheme 2](#sch0010){ref-type="fig"}, bottom). This modification occurs at the wobble position in mitochondrial tRNAs for lysine, glutamate and glutamine [@bb0220]. Detailed characterization of the bacterial protein complex of MnmE and MnmG (homolog of Mto1p) led to a mechanistic proposal in which the FAD-dependent MnmG serves a dual function during the reaction [@bb0215; @bb0225]. In this model, methylene tetrahydrofolate bound to MnmE reacts with either ammonia or glycine to form a methylene amino group at N-5 of the tetrahydrofolate cofactor. Then, FAD oxidizes the carbon--nitrogen bond to yield an imine, which is then nucleophilically attacked by the uracil base of the tRNA substrate. In the next step the reduced FAD transfers a hydride to the imine to reduce the carbon--nitrogen double bond thus completing the biosynthesis of the C-5 side chain (see [Scheme 2](#sch0010){ref-type="fig"}). Thus MnmG combines two canonical flavin-dependent reactions -- oxidation of amines and reduction of double bonds -- to catalyze the biosynthesis of the amino methyl or carboxymethylaminomethyl side chain.

Recently, yet another flavin-dependent enzyme encoded by *tyw1* ([Table 1](#t0005){ref-type="table"}, entry 25) was discovered that catalyzes the second step in the biosynthesis of wybutosine-modified tRNA [@bb0230]. This enzyme belongs to the radical SAM superfamily characterized by the presence of a \[4Fe--4S\] cluster and a *S*-adenosylmethionine (SAM) domain [@bb0235]. Catalytic activity requires reduction of the \[4Fe--4S\] cluster in order to initiate one-electron transfer for reductive cleavage of SAM to generate the 5′-deoxyadenosyl radical [@bb0240]. In vivo, flavodoxins or ferredoxins might act as potential electron donors to convert \[4Fe--4S\]^2 +^ to \[4Fe--4S\]^+^ and therefore it is conceivable that the N-terminal flavodoxin domain of Tyw1p relays electrons from an external electron donor such as NAD(P)H or an electron transfer protein to the \[4Fe--4S\] cluster. Such a functional role is supported by the finding that deletion of the flavodoxin domain abolishes TYW1p activity [@bb0245].

Interestingly, the yeast genome contains three homologous genes, *pst1*, *rfs1* and *ycp4* encoding three highly similar flavodoxin-like proteins ([Table 1](#t0005){ref-type="table"}, entry 46) [@bb0250]. Although none of the proteins was functionally characterized with respect to their electron transfer properties and physiological redox partners they were found to act as transcriptional regulators of *spi1*, a gene responding to various environmental stimuli [@bb0255]. The lack of information on yeast flavodoxins is very surprising in view of the abundance of structural (148 structures of wild-type and variants in the pdb) and biochemical studies available for bacterial flavodoxins. Therefore, the current state of affairs for yeast flavodoxin-like proteins is very unsatisfactory and clearly warrants further investigations to define their biochemical and structural properties.

The family of [d]{.smallcaps}-lactate dehydrogenases comprising three enzymes, Dld1-3p, will be discussed in the context of redox processes in the next section.

5. Yeast flavoproteins in redox balancing {#s0030}
=========================================

More than a quarter of yeast flavoproteins listed in [Table 1](#t0005){ref-type="table"} participate in redox reactions in the mitochondrion. As shown in [Scheme 1](#sch0005){ref-type="fig"}, transfer of electrons into the ETC can either occur through electron donation to cytochrome c (cyt. c) in the intermembrane space or directly by reduction of ubiquinone to ubiquinol in the inner mitochondrial membrane. The latter route is clearly the dominating process in yeast mitochondria. Electrons transferred to NAD^+^ in the isocitrate, α-ketoglutarate and malate dehydrogenase reactions of the tricarboxylic acid cycle enter the ETC. via the NADH:ubiquinone oxidoreductase Ndi1p ("internal NADH dehydrogenase"). In contrast to complex I of higher eukaryotes this membrane-bound enzyme does not engage in proton translocation resulting in lower phosphorylation efficiency. The oxidation of succinate to fumarate is catalyzed by a canonical membrane-bound succinate dehydrogenase in which the covalently linked FAD becomes reduced by the substrate and the electrons are passed on to ubiquinone via an iron--sulfur cluster and heme relay system. The Sdh1p subunit of yeast succinate dehydrogenase (complex II) is one of only two flavin-dependent proteins exhibiting a covalent linkage (see [Table 1](#t0005){ref-type="table"}, entry 9). Typically, covalent flavinylation is a spontaneous co- or posttranslational process. However, in the case of Sdh1p the assistance of Emi1p (Sdh5p) is required, which is conserved in higher eukaryotes and hence appears to be essential for complex II assembly [@bb0260; @bb0265]. Yeast also possesses a heterodimeric electron transfer flavoprotein (Aim45p/Cir1p) located in the mitochondrial matrix, which communicates with a membrane-bound electron transferring flavoprotein ubiquinone oxidoreductase (Cir2p). The latter flavoprotein feeds electrons received from Aim45p/Cir1p into the ETC. The clients for Aim45p/Cir1p, however, remain elusive as most electron donor proteins, such as the acyl-Co dehydrogenases involved in β-oxidation or amino acid degradation, are not present in *S. cerevisiae*. A potential candidate, [l]{.smallcaps}-proline dehydrogenase (Put1p), evidently feeds electrons from [l]{.smallcaps}-proline oxidation directly into the ETC. by reduction of ubiquinone to ubiquinol (see [Scheme 1](#sch0005){ref-type="fig"}) [@bb0270].

Cytosolic NADH generated for example by the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase is oxidized by either Nde1p or Nde2p ("external NADH:ubiquinone oxidoreductases") and the electrons serve to reduce ubiquinone ([Scheme 1](#sch0005){ref-type="fig"}). The mitochondrial ETC. can also be fuelled by the glycerol 3-phosphate shuttle: glycerol is first phosphorylated by glycerol kinase (Gut1p) in the cytosol and then transported to the intermembrane space to become oxidized by the membrane-bound glycerol 3-phosphate dehydrogenase (Gut2p) [@bb0275; @bb0280]. Several of the membrane-bound flavoproteins involved in substrate oxidation and electron transfer form a large supramolecular complex containing Nde1p, Nde2p and Gut2p and therefore inter-protein electron transfer may also occur prior to ubiquinone reduction [@bb0285].

Yeast possesses three [d]{.smallcaps}-lactate dehydrogenases (Dldp1-3, see [Table 1](#t0005){ref-type="table"}), which operate in different compartments of the cell: Dld1p is located in the inner mitochondrial membrane, Dld2p in the matrix and Ddl3 in the cytosol [@bb0290; @bb0295]. [d]{.smallcaps}-lactate is produced by the glyoxalase pathway that detoxifies methylglyoxal adventitiously generated by non-enzymatic elimination of hydrogen and phosphate from the enediol intermediate of triose phosphates [@bb0300]. Since this detoxification pathway is active in the cytosol and the mitochondrial matrix [d]{.smallcaps}-lactate dehydrogenase activity is required in these compartments to oxidize [d]{.smallcaps}-lactate to pyruvate ([Scheme 1](#sch0005){ref-type="fig"}). Oxidation of [d]{.smallcaps}-lactate by the [d]{.smallcaps}-lactate dehydrogenase (Dld2p) localized in the mitochondrial matrix is coupled to ATP synthesis and therefore Dld2p apparently donates substrate-derived electrons to the ETC [@bb0305]. However, it is currently unknown whether electrons are directly used to reduce ubiquinone or transferred to the heterodimeric Aim45p/Cir2p electron transfer complex ([Scheme 1](#sch0005){ref-type="fig"}).

The involvement of flavoproteins in central mitochondrial redox processes is also reflected by the fact that the flavin oxidation state oscillates in synchronized aerobically grown yeast cultures. During the oxidative phase of the culture the increase of flavin fluorescence indicates that more flavoproteins become oxidized whereas in the reductive phase of the internal rhythm a decrease of flavin fluorescence indicates a shift to the reduced state [@bb0310; @bb0315].

6. Flavin biosynthesis and transport {#s0035}
====================================

The biosynthesis of riboflavin in *S. cerevisiae* utilizes the canonical precursors, GTP and ribulose 5-phosphate. However, riboflavin biosynthesis deviates from the bacterial pathway in that deamination and reduction of the initial metabolite, 2,5-diamino-6-(ribosylamino)-4-(3H)-pyrimidinone 5′-phosphate (DRAP), take place in reverse order ([www.kegg.jp](http://www.kegg.jp){#ir0290}). Briefly, in the first step GTP is converted by GTP cyclohydrolase II, encoded by *rib1*, to DRAP, which is reduced by Rib7p to 2,5-diamino-6-(ribitylamino)-4-(3H)-pyrimidinone 5′-phosphate ([Table 2](#t0010){ref-type="table"} and [Scheme 3](#sch0015){ref-type="fig"}). This reaction is followed by deamination to 5-amino-6-ribitylamino-2,4-(1H,3H)-pyrimidinedione 5′-phosphate catalyzed by Rib2p [@bb0320]. After dephosphorylation by an unidentified phosphatase condensation with 3,4-dihydroxy-2-butanone-4-phosphate (DHAB) occurs. The latter metabolite is synthesized from ribulose 5-phosphate by DHBP synthase (encoded by *rib3*). The condensation reaction is catalyzed by lumazine synthase (encoded by *rib4*) and yields 6,7-dimethyl-8-(1-[d]{.smallcaps}-ribityl)lumazine [@bb0325; @bb0330]. In the final reaction, riboflavin synthase (encoded by *rib5*) uses two molecules of 6,7-dimethyl-8-(1-[d]{.smallcaps}-ribityl)-lumazine where one acts as donor and the other as acceptor of four carbon atoms leading to the generation of the isoalloxazine ring of one molecule of riboflavin [@bb0335]. The coenzyme forms of riboflavin, FMN and FAD, are synthesized from riboflavin by riboflavin kinase (Fmn1p) and FAD synthetase (Fad1p), respectively [@bb0340; @bb0345].

In addition to de novo biosynthesis, yeast is also capable of riboflavin uptake from the medium and it was shown that a plasma membrane flavin transporter, encoded by *mch5*, is regulated by the proline-dependent transcription factor Put3p [@bb0350; @bb0355]. Since proline utilization depends on the FAD-dependent proline dehydrogenase Put1p ([Table 1](#t0005){ref-type="table"}) upregulation of Mch5p suggests that riboflavin uptake is necessary under these conditions to meet the cellular demand for flavin coenzymes.

Despite the wealth of genetic and biochemical information available on riboflavin biosynthesis in the cytosol, transport to other compartments, in particular the mitochondrion as the dominant organelle for flavoenzyme catalyzed reactions, remains controversial [@bb0265]. Based on the finding that yeast mitochondria possess riboflavin kinase but no FAD synthetase activity, Tzagaloff et al. [@bb0360] proposed a model according to which the carrier protein Flx1p acts as a "flavin antiporter" by exchanging FMN from the mitochondrial matrix with FAD from the cytosol. In contrast to this model, Barile and coworkers claim that riboflavin is transported into mitochondria where both FMN and FAD can be synthesized and are even exported back to the "extramitochondrial phase" [@bb0365; @bb0370]. More recent data from Pallotta indicated that mitochondria can also hydrolyze FAD and FMN to riboflavin and are thus capable of balancing the pools of riboflavin, FMN and FAD [@bb0375]. Yeast FAD synthetase (Fad1p) is essential and deletion of *fad1* makes yeast unviable. The localization of yeast FAD1p is still unclear, although recent studies on human FAD synthetase isoform 1 (hFADS1) suggest a mitochondrial localization in eukaryotes [@bb0380].

In addition to *flx1* and *mch5*, yeast possesses three *flc* genes encoding putative transporters of flavins ([Table 2](#t0010){ref-type="table"}). These transporters are responsible for FAD transport into the endoplasmic reticulum (ER) where several flavoenzymes (e. g. Ero1p, Erv2p and Fmo1p) are involved in the redox balance of thiols and disulfide linkages [@bb0385]. However, the exact role and localisation of Flc1-3p in yeast are currently not fully understood.

An alternative mechanism for assembling the holo-flavoenzyme is realized for the sole peroxisomal flavoenzyme, acyl-CoA oxidase (Pox1p). In this case, the holo-enzyme is formed in the cytosol, then binds to the import receptor Pex5p and, following an unknown import pathway, is transported into the peroxisome [@bb0390; @bb0395].

7. Yeast flavoproteins as models for human diseases {#s0040}
===================================================

The yeast *S. cerevisiae* has been used as a model organism for studying fundamental biological processes for some time [@bb0400]. In 1997, Botstein and colleagues showed that nearly 31% of yeast open reading frames (ORF) have a homologue in mammalian genomes [@bb0405]. Since the number of annotated ORFs has almost doubled since 1997 this percentage is likely to have risen significantly. Moreover, an estimated 30% of human genes implicated in human diseases have a yeast homologue [@bb0410]. In a recent review, we have documented that fifty human flavoproteins are implicated in human diseases [@bb0140]. As shown in [Table 3](#t0015){ref-type="table"}, nearly half of the disease-related human flavoproteins possess a yeast homologue. Interestingly, the majority of disease-related human flavoproteins operate in the mitochondrion [@bb0140]. Owing to the similarity of mitochondrial processes in eukaryotes it is conceivable that the yeast homologs located in mitochondria (see [Table 3](#t0015){ref-type="table"}) may be particularly suitable as models for an improved understanding of human mitochondrial diseases.

Functional assignments based on sequence similarity generated ambiguities for several flavoproteins. For example, the yeast [d]{.smallcaps}-lactate dehydrogenases (Dld1-3p) show remarkable similarity to human [d]{.smallcaps}-2-hydroxyglutarate dehydrogenase and to a much lesser degree to alkyldihydroxyacetone phosphate synthase. Similarly, the yeast glutamate synthase, Glt1p, exhibits similarity to human dihydropyrimidine dehydrogenase (see [Table 3](#t0015){ref-type="table"}). On the other hand the yeast NAD(P)H:quinone oxidoreductase Lot6p shows only a very low similarity to the human ortholog (P = 1) although it possesses a similar structure and function [@bb0415; @bb0420; @bb0425; @bb0430]. These examples illustrate the need for biochemical characterization to provide a solid basis for comparative functional studies.

Yeast deletion strains were also used as convenient models to investigate the impact of mutations discovered in human genes. Examples are deletions of the genes *ura1*, *sdh1*, *ldp1* and *coq6*, leading to auxotrophic yeast strains, which were complemented with the orthologous human gene to investigate the functional impairment of mutations [@bb0435; @bb0440; @bb0445; @bb0450]. Yeast was also utilized as a host for heterologous expression of the human gene encoding 3β-hydroxysterol Δ24-reductase (DHCR24). Desmosterolosis, a rare autosomal recessive disorder is caused by mutations in the gene encoding DHCR24. Heterologous expression of the human *DHCR24* gene bearing different missense mutations confirmed their role in desmosterolosis [@bb0455].

A genetic screen in yeast suggested that kynurenine 3-monooxygenase may be a useful therapeutic target for Huntington disease [@bb0460]. This has prompted structural studies with the yeast enzyme leading to the elucidation of its X-ray crystal structure, which may serve as a model to investigate the structural basis of inhibitor binding [@bb0150]. Similarly, the crystal structure of the yeast flavin-containing monooxygenase Fmo1p proved useful as a model to understand the effect of mutations in human FMO3 that cause trimethylaminuria ("fish-odor" syndrome) [@bb0465].

8. Concluding remarks {#s0045}
=====================

Our analysis of the yeast flavoproteome has highlighted the importance of flavin-dependent enzymes in mitochondrial redox processes. Many of these mitochondrial enzymes have human homologs involved in diseases and thus genetically manipulated yeast strains (e.g. gene deletions) have potential as convenient model systems. On the other hand, many yeast flavoenzymes are barely characterized with regard to their biochemical properties, such as substrate specificity, kinetic parameters and reaction partners. This deficit is clearly illustrated by the yeast flavodoxin-like proteins and the electron-transferring flavoprotein, none of which were characterized in any biochemical or structural detail. Similarly, our understanding of riboflavin uptake and trafficking between cellular compartments as well as flavin homeostasis are at an early stage necessitating further studies. Since these processes are also poorly understood in humans, yeast lends itself as a valuable model organism to gain insight into uptake, transport and trafficking of this vital vitamin.

9. Methods {#s0005}
==========

The names and gene abbreviations of yeast flavoproteins were recently compiled for a review article [@bb0135]. This list of flavoproteins was updated using the information available in the *Saccharomyces* genome database (<http://www.yeastgenome.org/>). This database was also used to extract information on viability of gene knock-outs and localisation of flavoproteins in the yeast cell. Structural information was obtained from the protein database (<http://www.pdb.org>).
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![Flavoproteins in mitochondrial redox processes.\
Flavoproteins are represented by yellow spheres (soluble flavoproteins in the matrix or intermembrane space) or barrels (inner or outer mitochondrial membrane). Flavoproteins with a covalently bound FAD (Sdh1p in the inner and Alo1p in the outer membrane) are shown in light orange. Cytochrome c is shown as a light green sphere. Curved blue arrows indicate redox reactions and straight arrows electron transfer. For further explanations and comments see main text. Several flavoproteins appear to participate in a multi-protein complex in the inner mitochondrial membrane [@bb0285]. For clarity, we have shown only a complex consisting of Ndi1p, Nde1/2p and Gut1p. Abbreviations used are: DHAP, dihydroxy acetone phosphate; Gly3p, glycerol 3-phosphate; GluSA, γ-glutamic acid semialdehyde; Mia(40), mitochondrial intermembrane space import and assay/oxidoreductase 40 (ox, oxidized; red, reduced); Q, ubiquionone.](sc1){#sch0005}

![Flavoproteins in tRNA-modification.\
Top, reaction catalyzed by tRNA-dihydrouridine synthase (Dus1-4p); Bottom, reaction catalyzed by Mto1p/Mss1p. Depending on the co-substrate, ammonia or glycine, the side chain in position 5′ of the uracil base is aminomethyl or carboxymethylaminomethyl. "R" represents the next 3′-nucleotide in the tRNA molecule.](sc2){#sch0010}

![Biosynthesis of riboflavin in *S. cerevisiae*.\
GTP and [d]{.smallcaps}-ribulose-5-phosphate serve as building blocks for the biosynthesis of 5-amino-6-ribityl-aminouracil and 3,4-dihydroxy-2-butanone-4-phosphate, respectively. These two compounds are then used by Rib4p to synthesize 6,7-dimethyl-8-ribityl lumazine. Two molecules 6,7-dimethyl-8-ribityl lumazine areconverted by Rib5p to riboflavin and 5-amino-6-ribityl-aminouracil which serves again as substrate for Rib4p. This way all atoms of the dimethylbenzene moiety are derived from 3,4-dihydroxy-2-butanone-4-phosphate (colored in blue and green) while remainder of riboflavin is derived from GTP (colored in red).](sc3){#sch0015}

###### 

Yeast flavoproteins and genes.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.   E.C.         Enzyme                                                                                               Cofactor             Structure clan (family)[a](#tf0005){ref-type="table-fn"}   Localization                               Abbrev.   Syst. name
  ----- ------------ ---------------------------------------------------------------------------------------------------- -------------------- ---------------------------------------------------------- ------------------------------------------ --------- ------------
  1     1.1.2.3      [l]{.smallcaps}-Lactate:cytochrome c oxidoreductase (flavocytochrome b~2~)                           FMN/heme             TIM_barrel (FMN_dh)                                        Mito. intermembr. sp.                      *cyb2*    YML054C

  2     1.1.2.4      [d]{.smallcaps}-Lactate dehydrogenase                                                                FAD/heme             --                                                         I. mito. membr.                            *dld1*    YDL174C

                                                                                                                                                                                                          Mito. matrix                               *dld2*    YDL178W

                                                                                                                                                                                                          Cytoplasm                                  *dld3*    YEL071W

  3     1.1.3.37     [d]{.smallcaps}-Arabino-1,4-lactone oxidase                                                          8α-(N3-His)\         *FAD_PCMH*                                                 O. mito. membr.                            *alo1*    YML086C
                                                                                                                          -FAD                                                                                                                                 

  4     1.1.5.3      Glycerol-3-phosphate dehydrogenase                                                                   FAD                  *NADP_Rossmann (DAO)*                                      I. mito. membr.                            *gut2*    YIL155C

  5     1.3.1.90     tRNA dihydrouridine synthase                                                                         FMN                  *TIM_barrel (Dus)*                                         Nucleus                                    *dus1*    YML080W

                                                                                                                                                                                                          Nucleus/cytoplasm                          *dus2*    YNR015W

                                                                                                                                                                                                          Nucleus/cytoplasm                          *dus3*    YLR401C

                                                                                                                                                                                                          --                                         *dus4*    YLR405W

  6     1.3.3.1      Dihydroorotate dehydrogenase                                                                         FMN                  *TIM_barrel (DHO_dh)*                                      Cytoplasm                                  *ura1*    YKL216W

  7     1.3.3.4      Protoporphyrinogen IX oxidase                                                                        FAD                  *NADP_Rossmann (Amino_oxidase)*                            I. mito. membr.                            *hem14*   YER014W

  8     1.3.3.6      Acyl-CoA oxidase                                                                                     FAD                  *Acyl-CoA_dh (ACOX, acyl-CoA_dh_1)*                        Peroxisome                                 *pox1*    YGL205W

  9     1.3.5.1      Succinate dehydrogenase                                                                              8α-(N3-His)          *NAPH_Rossmann*                                            I. mito. membr.                            *sdh1*    YKL148C

                     Flavoprotein subunit A                                                                               -FAD/2Fe-2S/         *(FAD_binding_2)*                                                                                     *sdh1b*   YJL045W

        --           Protein required for flavinylation of sdh                                                            --                   --                                                         I. mito. membr.                            *emi5*    YOL071W

  10    1.4.1.14     NAD-dependent glutamate synthase                                                                     FMN/3Fe-4S           *Glu_synthase/Glu_syn_central*                             Mito. matrix                               *glt1*    YDL171C

  11    1.4.3.5      Pyridoxal 5′-phosphate oxidase                                                                       FMN                  FMN-binding                                                Mito. intermembr. sp.                      *pdx3*    YBR035C

                     Pyridoxine 5′-phosphate oxidase                                                                                           (Pyridox_oxidase)                                                                                               

  12    1.4.3.17     Polyamine oxidase                                                                                    FAD                  NADP_Rossmann                                              cytoplasm                                  *fms1*    YMR020W

                                                                                                                                               (FAD_binding_2)                                                                                                 

  13    1.5.1.20     Methylenetetrahydrofolate reductase                                                                  FAD                  *FAD_oxidored (MTHFR)*                                     --                                         *met12*   YPL023C

                                                                                                                                                                                                          Mito.                                      *met13*   YGL125W

  14    1.5.5.1      Electron-transferring flavoprotein-ubiquinone oxidoreductase                                         FAD/4Fe--4S          *4Fe--4S (ETF_QO)*                                         I. mito. membr.                            *cir2*    YOR356W

  15    --           Electron transferring flavoprotein                                                                   FAD                  *FAD_DHS (ETF_alpha)*                                      Mito. matrix                               *aim45*   YPR004C

  16    1.5.99.8     Proline dehydrogenase                                                                                FAD                  *FAD_oxidored (Pro_dh)*                                    Mito. matrix                               *put1*    YLR142W

  17    1.6.2.2      Cytochrome-b5 reductase                                                                              FAD                  *FAD_Lum_binding*                                          ER & o. mito. membr.                       *cbr1*    YIL043C

                                                                                                                                               *(FAD_binding_6)*                                          ER & plasma membr.                         *pga3*    YML125C

  18    1.6.2.4      NADPH-hemoprotein reductase                                                                          FMN/heme             Flavoprotein (Flavodoxin_1)                                O. mito. membr.,                           *ncp1*    YHR042W

                     (cytochrome P450 reductase)                                                                          FAD                  FAD_Lum_binding                                            ER & plasma membr.                                   

                                                                                                                                               (FAD_binding_1)                                                                                                 

  19    1.6.5.2      NAD(P)H quinone oxidoreductase                                                                       FMN                  Flavoprotein (Flavodoxin_2)                                cytoplasm                                  *lot6*    YLR011W

  20    1.6.5.9      NADH-ubiquinone oxidoreductase (rotenone-insensitive)                                                FAD/Fe-S             NADP_Rossmann (Pyr_redox_2)                                I. mito. membr.                            *ndi1*    YML120C

  21    1.6.99.1     NADPH dehydrogenase                                                                                  FMN                  TIM_barrel (Oxidored_FMN)                                  Cytoplasm                                  *oye2*    YHR179W

                                                                                                                                                                                                                                                     *oye3*    YPL171C

  22    1.--.--.--   External NADH dehydrogenase                                                                          FAD                  --                                                         I. mito. membr.                            *nde1*    YMR145C

                                                                                                                                                                                                          I. mito. membr.                            *nde2*    YDL085W

  23    1.6.--.--    NADPH-dep. diflavin oxidoreductase                                                                   FMN                  *Flavoprotein (Flavodoxin_1)*                              Mito. matrix                               *tah18*   YPR048W

                                                                                                                          FAD                  *FAD_Lum_binding*                                                                                               

                                                                                                                                               *(FAD_binding_1)*                                                                                               

  24    --           5-Carboxymethylaminomethylation of uridine (heterodimer with Mss1p)                                  FAD                  *GIDA*                                                     Mito.                                      *mto1*    YGL236C

  25    --           Wybutosine biosynthesis, a tRNA-modification                                                         FMN/4Fe--4S          *Flavoprotein*                                             ER                                         *tyw1*    YPL207W

  26    1.8.1.2      Sulphite reductase (beta subunit)                                                                    FMN/heme             *Flavoprotein (Flavodoxin_1)*                              Cytoplasm                                  *met5*    YJR137C

                                                                                                                          FAD                  *FAD_Lum_binding*                                                                                               

                                                                                                                                               *(FAD_binding_1)*                                                                                               

  27    1.8.1.4      Dihydrolipoyl dehydrogenase                                                                          FAD                  NADP_Rossmann                                              Mito. matrix                               *lpd1*    YFL018C

                                                                                                                                               (Pyr_redox_2)                                                                                                   

  28    1.8.1.7      Glutathione-disulfide reductase                                                                      FAD                  NADP_Rossmann (Pyr_redox_2)                                Cytoplasm & mito.                          *glr1*    YPL091W

  29    1.8.1.9      Thioredoxin-disulfide reductase                                                                      FAD                  NADP_Rossmann (Pyr_redox_2)                                Cytoplasm & mito. intermembr. sp.          *trr1*    YDR353W

                                                                                                                                                                                                          Cytoplasm & mito.                          *trr2*    YHR106W

  30    --           Microtubule associated protein                                                                       FAD                  *NADP_Rossmann?*                                           cytoplasm                                  *irc15*   YPL017C

                                                                                                                                               *(Pyr_redox_2)*                                            microtubule                                          

  31    1.8.3.2      Sulfhydryl oxidase                                                                                   FAD/Fe--S cluster/   Erv1_Alr                                                   Mito. intermembr. sp.                      *erv1*    YGR029W

                                                                                                                          Heme                                                                            ER membr.                                  *erv2*    YPR037C

  32    1.8.4.-      Endoplasmic oxidoreductin 1                                                                          FAD                  Ero1                                                       ER & ER membr.e                            *ero1*    YML130C

  33    1.14.12.17   Nitric oxide oxidoreductase                                                                          FAD/heme             FAD_Lum_Binding                                            Cytoplasm                                  *yhb1*    YGR234W

                     (flavohemoglobin)                                                                                                         (FAD_binding_6)                                            Mito. matrix                                         

  34    1.14.13.--   Oxidase of thiols in the ER                                                                          FAD                  --                                                         ER membr.                                  *fmo1*    YHR176W

  35    1.14.13.9    Kynurenine 3-monooxygenase                                                                           FAD                  NADP_Rossmann (FAD_Binding_3)                              O. mito. membr.                            *bna4*    YBL098W

  36    1.14.99.7    Squalene monooxygenase                                                                               FAD                  --                                                         ER membr.                                  *erg1*    YGR175C

  37    1.14.99.-    Monooxygenase in coenzyme Q biosyn.                                                                  FAD                  --                                                         I. mito. membr.                            *coq6*    YGR255C

  38    1.--.--.--   Ferric reductase                                                                                     FAD/heme             --                                                         Plasma membr.                              *fre1*    YLR214W

                                                                                                                                                                                                          Plasma membr.                              *fre2*    YKL220C

                                                                                                                                                                                                          Plasma membr.                              *fre3*    YOR381W

                                                                                                                                                                                                          Plasma membr.                              *fre4*    YNR060W

                                                                                                                                                                                                          *Plasma membr.*                            *fre5*    YOR384W

                                                                                                                                                                                                          *Vacuole membr.*                           *fre6*    YLL051C

                                                                                                                                                                                                          *Plasma membr.*                            *fre7*    YOL152W

                                                                                                                                                                                                          --                                         *fre8*    YLR047C

  39    1.--.--.--   NADPH oxidase                                                                                        FAD/heme             --                                                         Perinucl. ER membr.                        *aim14*   YGL160W

  40    1.--.--.--   NAD(P)H-dep. heme reductase                                                                          FAD                  --                                                         Inner mito. membr.                         *cyc2*    YOR037W

  41    2.2.1.6      Acetolactate synthase                                                                                FAD/TPP              FAD_DHS (TPP_enzyme_M)                                     Mito.                                      *ilv2*    YMR108W

  42    2.3.1.86     Fatty acid synthase, subunit β, chain I                                                              FMN                  Not reported                                               Cytoplasm & mito.                          *fas1*    YKL182W

  43    4.1.1.36     4′-Phosphopantothenoylcysteine decarboxylase (forms a heterotrimeric complex with Sis2p and Vhs3p)   FMN                  *Flavoprotein*                                             Cytoplasm                                  *cab3*    YKL088W

  44    4.1.99.3     Deoxyribodipyrimidine photo-lyase                                                                    ^FAD^                *HUP (DNA_photolyase)*                                     Cytoplasm, mito. & nucleus                 *phr1*    YOR386W

  45    4.2.3.5      Chorismate synthase                                                                                  FMN                  Chorismate_synt                                            Cytoplasm                                  *aro2*    YGL148W

  46    --           Flavodoxin-like protein                                                                              FMN                  *Flavoprotein (Flavodoxin_1)*                              Cytoplasm, mito.                           *pst2*    YDR032C

        --           Flavodoxin-like protein                                                                              FMN                  *Flavoprotein (Flavodoxin_1)*                              Cytoplasm                                  *rfs1*    YBR052C

        --           flavodoxin-like protein                                                                              FMN                  *Flavoprotein (Flavodoxin_1)*                              Cytoplasm, mito.                           *ycp4*    YCR004C

  47    --           Apoptosis-inducing factor                                                                            FAD                  --                                                         O. mito. membr., plasma membr. & nucleus   aif1      YNR074C
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations used in Table 1: biosyn., biosynthesis; dh, dehydrogenase; degr., degradation; dep., dependent; i., inner; ER, endoplasmic reticulum; mito., mitochondrion; o., outer; perinucl., perinuclear; red., reductase; sp., space.

Pfam classification given in plain text is for yeast proteins and those in italics are for homologs from other species.

###### 

Yeast flavin transporters and biosynthesis.

  No.                                         E.C.        Protein/enzyme                           Substrate/ligand   Structure clan (family)[a](#tf0010){ref-type="table-fn"}   Abbrev.   Syst. name
  ------------------------------------------- ----------- ---------------------------------------- ------------------ ---------------------------------------------------------- --------- ------------
  *Transporters*                                                                                                                                                                           
  1                                           --          FAD transmembrane transporter            FAD                --                                                         *flx1*    YIL134W
  2                                           --          FAD transporter (into ER)                FAD                --                                                         *flc1*    YPL221W
  3                                           --          FAD transporter (into ER)                FAD                --                                                         *flc2*    YAL053W
  4                                           --          FAD transporter (into ER)                FAD                --                                                         *flc3*    YGL139W
  5                                           --          Plasma-membrane riboflavin transporter   Riboflavin         --                                                         mch5      YOR306C
                                                                                                                                                                                           
  *Biosynthesis of riboflavin, FMN and FAD*                                                                                                                                                
  1                                           3.5.4.25    GTP cyclohydrolase II (1st step)         --                 *GTP cyclohydrolase II*                                    *rib1*    YBL033C
  2                                           1.1.1.302   DRAP reductase (2nd step)                --                 DHFred (RibD_C)                                            *rib7*    YBR153W
  3                                           --          Deaminase (3rd step)                     --                 *DHFred (RibD_C)*                                          *rib2*    YOL066C
  4                                           4.1.99.12   DHBP synthase (4th step)                 --                 *DHBP_synthase*                                            *rib3*    YDR487C
  5                                           2.5.1.78    Lumazine synthase (5th step)             --                 DMRL_synthase                                              *rib4*    YOL143C
  6                                           2.5.1.9     Riboflavin synthase (6th step)           --                 *FAD_Lum_binding (Lum_binding)*                            *rib5*    YBR256C
  7                                           2.7.1.26    Riboflavin kinase                        Riboflavin         *Flavokinase*                                              *fmn1*    YDR236C
  8                                           2.7.7.2     FAD-adenylyl transferase (synthetase)    FMN                HUP (PAPS_reduct)                                          *fad1*    YDL045C

Abbreviations used in Table 2 are: DHBP, 3,4-dihydroxy-2-butanone-4-phosphate; DRAP, 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5′-phosphate.

Pfam classification given in plain text is for yeast proteins and those in italics are for homologs from other species.

###### 

Yeast flavoproteins as human disease models.

  No.   E.C.         Human enzyme                                               Disease                                         OMIM                        Yeast homolog   E value[a](#tf0015){ref-type="table-fn"}
  ----- ------------ ---------------------------------------------------------- ----------------------------------------------- --------------------------- --------------- ------------------------------------------
  1     1.1.5.3      Glycerol 3-phosphate dh                                    *Diabetes mellitus*, type 2                     [138430](138430){#ir0155}   Gut2p           7.3 e − 124
  2     1.1.99-      [d]{.smallcaps}-2-Hydroxyglutarate dh                      [d]{.smallcaps}-2-Hydroxyglutaric aciduria      [605176](605176){#ir0160}   Dld1p           1.9 e − 39
                                                                                                                                                            Dld2p           8.7 e − 128
                                                                                                                                                            Dld3p           3.3 e − 112
  3     1.3.1.2      Dihydropyrimidine dh                                       Deficiency                                      [612779](612779){#ir0165}   Glt1p           2.7 e − 14
  4     1.3.5.2      Dihydroorotate dh                                          Miller syn.                                     [126064](126064){#ir0170}   Ura1p           2.0 e − 6
  5     1.3.3.4      Protoporphyrinongen IX ox.                                 Variegate porphyria                             [600923](600923){#ir0175}   Hem1p           7.2 e − 20
  6     1.3.3.6      Acyl-CoA ox.                                               Deficiency                                      [609751](609751){#ir0180}   Pox1p           2.0 e − 45
  7     1.3.5.1      Succinate dh                                               Complex II deficiency,                          [600857](600857){#ir0185}   Sdh1p           3.9 e − 219
                     Flavoprotein subunit A                                     Leigh syn., paraganglioma 5                                                 Sdh1bp          3.0 e − 214
  8     1.4.3.4      Monoamine ox                                               Brunner syn., antisocial behavior, autism       [309850](309850){#ir0190}   Fms1p           7.8 e − 11
  9     1.4.3.5      Pyridoxine 5′-phosphate ox.                                Encephalopathy                                  [603287](603287){#ir0195}   Pdx3p           5.1 e − 36
  10    1.5.1.20     Methylenetetrahydofolate red.                              Homocystinuria, neural tube                     [607093](607093){#ir0200}   Met12p          2.9 e − 98
                                                                                Defects, schizophrenia                                                      Met13p          7.5 e − 122
  11    1.5.5.1      Electron-transferring flavo-protein ubiquinone oxidored.   Glutaric academia IIC                           [231675](231675){#ir0205}   Cir2p           8.0 e − 157
  12    --           Electron-transferring flavoprot.                           Glutaric acidemia IIA                           [608053](608053){#ir0210}   Aim45p          8.5 e − 66
                                                                                Glutaric acidemia IIB                           [130410](130410){#ir0215}                   
  13    1.5.99.8     Proline dh                                                 Hyperprolinemia type I, schizophrenia           [606810](606810){#ir0220}   Put1p           8.7 e − 12
  14    1.6.2.2      Cytochrome-b5 red.                                         Methemoglobinemia types I & II                  [613213](613213){#ir0225}   Cbr1p           1.9 e − 30
  15    1.6.2.4      NADPH-hemoprotein red. (cytochrome P450 red.)              Antley--Bixler syn.,                            [124015](124015){#ir0230}   Ncp1p           2.4 e − 86
  16    1.6.5.2      NAD(P)H:quinone oxidored.                                  Benzene toxicity, breast cancer                 [125860](125860){#ir0235}   Lot6p           1
  17    1.8.1.4      Dihydrolipoyl dh                                           Leigh syn., maple syrup urine disease           [238331](238331){#ir0240}   Lpd1p           2.8 e − 147
  18    1.8.1.7      Glutathione-disulfide red.                                 Hemolytic anemia                                [138300](138300){#ir0245}   Glr1p           1.4 e − 104
  19    1.14.13.8    Flavin-containing monooxy.                                 Trimethylaminuria                               [136132](136132){#ir0250}   Fmo1p           4.8 e − 27
  20    1.14.13.39   Nitric-oxide synthase                                      Hypertension                                    [163729](163729){#ir0255}   Tah18p          9.6 e − 27
                                                                                                                                [163730](163730){#ir0260}                   
  21    1.14.99.-    Monooxy. in coenzyme Q                                     Deficiency, nephrotic syn.                      [614647](614647){#ir0265}   Coq6p           7.0 e − 55
  22    1.16.1.8     Methionine synthase red.                                   Homocystinuria, neural tube                     [602568](602568){#ir0270}   Met5p           0.24
  23    2.5.1.26     Alkyldihydroxyacetone                                      Rhizomelic chondrodysplasia                     [603051](603051){#ir0275}   Dld1p           2.1 e − 25
                     Phosphate synthase                                         Punctata type 3                                                             Dld2p           4.4 e − 16
                                                                                                                                                            Dld3p           1.1 e − 15
  24    --           Apoptosis inducing protein                                 Combined oxidative phosphorylation deficiency   [300169](300169){#ir0280}   Aif1p           8.8 e − 4

Abbreviations used in Table 3: dh, dehydrogenase; flavoprot., flavoprotein; monooxy., monooxygenase; ox, oxidase; oxidored., oxidoreductase; red., reductase; syn., syndrome.

E value; expect value, was generated by searching of *Saccharomyces* Genome Database (SGD; <http://www.yeastgenome.org>) open reading frames (DNA or protein) against human protein sequences using the SGD WU_Blast2 program.
